Inactivated Polio and Rabies Vaccines Market
The growth of the market for Inactivated Polio and Rabies Virus Vaccines is expected to be fueled by increasing incidences of these diseases. Inactivated Polio and Rift Virus Vaccines are used to protect people against rabies. They are given in a single injection in the arm or leg and contain 2.5 IU of rabies virus antigen per dose.
It is produced by growing the micro-organism (bacteria or viruses) on the culture medium, then inactivating them with heat and / or chemicals (formalin is mostly used for inactivation). Therefore, the components of the inactivated vaccine cannot replicate. It classified into two types such as whole killed vaccine and subunit vaccine.
The global inactivated polio and rabies vaccines market is estimated to be valued at US$ 966.6 Mn in 2019 and is expected to increase to US$ 1,418.2 Mn by 2027, exhibiting a CAGR of 4.9% over the forecast period (2019-2027)
𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/3581
Growing U.S. Food and Drug Administration (U.S. FDA) approvals for inactivated vaccines and their launches (IPV and IRV) are projected to foster the global inactivated polio and rabies vaccines market growth over the forecast period.
Key players are involved in research, launches, and approvals of inactivated vaccines in the global inactivated polio and rabies vaccines market. For instance, in June 2019, AJ Vaccines introduced adjuvant IPV vaccine in Denmark. It is different from already available IPV vaccines, as it offer enhanced immunization to the infants and children from polio owing to the presence of adjuvant and lower doses of vaccine that is required for immunization. Moreover, recently some new vaccines against rabies received U.S. Food and Drug Administration (U.S. FDA) approvals. For instance, in October 2019, Sanofi Pasteur SA announced to receive the U.S. FDA approval of Imovax, and in 2018, GlaxoSmithKline Biologicals, announced to receive the U.S. FDA approval for RabAvert. Both the vaccines can be used for pre-exposure immunization and post-exposure treatment of rabies.
Growing incidences of rabies in the population is again projected to uplift the global inactivated polio and rabies vaccines market growth over the forecast period
According to Center for Disease Control and Prevention, (CDC), 2019, in U.S., it has been reported that, other than dog, other animals are also responsible for spreading rabies in humans. For instance, according to the same source, in the U.S., during 2008-2017, 23 people were reported to be suffering from rabies, of which, eight people contracted rabies outside the U.S. The source of the rabies was checked and found that dog, bat, raccoon, and fox were found to be the carriers of rabies and rabies causes around 59,000 deaths world-wide every year. Despite of the availability of vaccine over 100 years, dog rabies have found to be common in the all regions with inadequate public health resources and having limited access to preventive treatment.
Growing awareness regarding polio among the population is projected to drive the global inactivated polio and rabies vaccines market growth over the forecast period.
According to WHO, 2018, world-wide incidences of polio have been decreased by 99%, since 1988 and only 22 cases of children suffering from polio were found in 2017. Moreover, only three countries such as Pakistan, Afghanistan, and Nigeria were not successful in eradicating polio from their countries. According to the same source, it has also been estimated that failure to eradicate polio, over the span of ten years, can result in 200,000 polio patients globally. Furthermore, active participation of government for raising awareness among the population through social media platforms, newspapers, and announcements is projected to reduce number of polio cases world-wide.
𝐓𝐨 𝐆𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐇𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/3581
Global Inactivated Vaccines Market – Regional Analysis
Regional segmentation of the global inactivated polio and rabies vaccines market comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold dominant position in the global inactivated polio and rabies vaccine market over the forecast period, due to the growing expenditure for maintaining rabies and polio free conditions in the region. Moreover, high income regions such as North America, Europe, and Latin America have eliminated cases of patients suffering from rabies and polio from their regions by growing awareness among the population and conducting vaccination drives against rabies and polio, all over the region. High income regions incur very high expenditure, in order to maintain rabies and polio free environment and to survey any occurrence of the disease in the regions.
Moreover, according to the World Health Organization (WHO), 2019, low income regions such as Asia Pacific, Africa, and Latin America have reported highest number of deaths in the population because of rabies. For instance, according to the same source, per year around, 35,172 human deaths and 21,476 human deaths occur due to rabies in Asia Pacific and Africa respectively. The cases of patients suffering from polio in Asia Pacific are reducing because of increasing awareness regarding the prevention of polio and rabies among the population and free immunization camps, which are organized by the government for immunizing the population against polio and rabies. Thus, Asia Pacific is also projected to spur the global inactivated polio and rabies vaccines market growth over the forecast period.
Global Inactivated Polio and Rabies Vaccines Market – Restraints
Factor that can hamper the global inactivated vaccines market growth include safety of the vaccines. For example, the inactivation process of the viruses may remain incomplete and the active virus may spread among the population causing the disease. Moreover, unavailability of the vaccines is another major factor that is projected to hamper growth of the global inactivated vaccines market. For instance, in India, the polio drive, which was scheduled on 3rd February 2019, was postponed till 10th March 2019, due to unavailability of the polio vaccine.
Key Players
Bharat Biotech., BIO-MED, Serum Institute of India Pvt. Ltd., Kedrion Biopharma Inc. GlaxoSmithKline plc. Bilthoven Biologicals, Merck & Co., Inc., and Pfizer Inc.
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/3581
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Vaccine
- Market Snippet, By Method of Inactivation
- Market Snippet, By Age Group
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Industry Trend
- Mergers and Acquisitions
- Technology Overview
- Promotion Initiatives
- Market Dynamics
- Global Inactivated Polio and Rabies Vaccines Market, By Vaccine, 2019 – 2027 (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Inactivated Polio Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Inactivated Rabies Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Inactivated Polio and Rabies Vaccines Market, By Method of Inactivation, 2019 – 2027 (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Solvent Detergent Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Radiation Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- pH Concentration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Heat Inactivation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Inactivated Polio and Rabies Vaccines Market, By Age Group, 2019 – 2027 (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Inactivated Polio and Rabies Vaccines Market, By Distribution Channel, 2019 – 2027 (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Government
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/inactivated-polio-and-rabies-vaccines-market-2885
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.